05/20/2025
6:27 PM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
6:28 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
6:28 PM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
10:44 AM | Capital World Investors (Filed by)
KalVista Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
04/11/2025
4:22 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2025
6:30 AM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2025
3:31 PM | KalVista Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/10/2025
5:43 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
7:35 PM | KalVista Pharmaceuticals (Issuer)
Piekos Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
7:36 PM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
7:36 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for KALV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
02/25/2025
7:37 PM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
7:46 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
7:46 PM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
7:47 PM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
6:45 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
6:51 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:43 PM | KalVista Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/03/2025
6:39 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/03/2025
6:42 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
3:57 PM | KalVista Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/16/2024
6:07 AM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
8:08 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:17 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
3:07 PM | KalVista Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/27/2024
7:43 PM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
7:45 PM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
3:41 PM | KalVista Pharmaceuticals (Issuer)
Reid Laurence (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
6:06 AM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2024
6:18 PM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
6:18 PM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
6:19 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
11:54 AM | Capital World Investors (Filed by)
KalVista Pharmaceuticals (Subject)
| Form SC 13G | |
11/12/2024
8:31 AM | Adage Capital Management, L.P. (Filed by)
KalVista Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/07/2024
1:34 PM | Frazier Life Sciences Public Fund, L.P. (Filed by)
KalVista Pharmaceuticals (Subject)
| Form SC 13D/A | |
11/04/2024
3:40 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
11:00 AM | KalVista Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
6:00 AM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
3:05 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
3:06 PM | KalVista Pharmaceuticals (Issuer)
Unkart Edward W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:07 PM | KalVista Pharmaceuticals (Issuer)
Treanor Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The MAGA 7 Stocks: Huge Upside in 2025 (Ad) The Trump economy is back in full force, and it’s creating huge opportunities for investors.
With Trump pushing for lower taxes, fewer regulations, tariffs on foreign competitors, and domestic manufacturing dominance, some stocks are set to skyrocket in value—while others will be left behind.
That’s why we put together this free report revealing the 7 MAGA stocks poised to thrive in 2025. 🔻 Download the full report now and get the inside track on these 7 powerhouse stocks. |
10/04/2024
3:07 PM | KalVista Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:08 PM | KalVista Pharmaceuticals (Issuer)
Pereira Brian JG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:08 PM | Fairey William (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:32 PM | KalVista Pharmaceuticals (Issuer)
Piekos Brian (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/11/2024
3:34 PM | KalVista Pharmaceuticals (Issuer)
Piekos Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
7:31 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
3:39 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:24 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:07 PM | KalVista Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/26/2024
6:58 PM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
7:00 PM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:13 PM | KalVista Pharmaceuticals (Filer)
| Form DEFA14A | |
08/22/2024
3:17 PM | KalVista Pharmaceuticals (Filer)
| Form ARS | |
08/22/2024
3:08 PM | KalVista Pharmaceuticals (Filer)
| Form DEF 14A | |
08/21/2024
8:25 PM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
8:25 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
8:26 PM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
3:23 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/21/2024
11:15 PM | KalVista Pharmaceuticals (Filer)
| Form EFFECT | |
07/11/2024
3:49 PM | KalVista Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/28/2024
3:21 PM | KalVista Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/10/2024
5:42 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy KALV Stock Free KALV Stock Alerts